Department of Clinical Science and Education, Karolinska Institute, Unit of Cardiology, Södersjukhuset, Stockholm 11883, Sweden.
J Interv Cardiol. 2020 May 12;2020:4829647. doi: 10.1155/2020/4829647. eCollection 2020.
The index of microcirculatory resistance is an invasive measure of coronary microvascular function that has to be calculated during maximal hyperemia, classically achieved with intravenous adenosine (IV). The aim of this study was to evaluate the use of intracoronary (IC) adenosine for the calculation of IMR.
31 patients with stable coronary artery disease were included in the study. Coronary pressure and thermodilution measurements were obtained at rest and during maximal hyperemia using a pressure-temperature sensor-tipped coronary guidewire. Duplicate measurements were performed using first IC and then IV adenosine. Dispersion of transit times was comparable for IC and IV adenosine. IMR values based on IC vs IV adenosine showed a high level of agreement and an intraclass correlation coefficient of 0.90. Applying an upper normal limit of 25, misclassification of IMR using IC adenosine was seen in just one patient in whom IC adenosine resulted in a lower value. A simplified procedure based on a single bolus dose of saline did not change the level of agreement or the rate of misclassification.
We found an excellent agreement between IMR values measured during hyperemia induced by IC as compared to IV adenosine. The use of IC adenosine may facilitate invasive assessment of microvascular function and is potentially time- and cost-saving with less patient discomfort as compared to IV infusion. The trail is registered with NCT03369184.
微血流阻力指数是一种有创性的冠状动脉微血管功能检测指标,需要在最大充血状态下进行计算,经典的方法是静脉内注射腺苷(IV)。本研究旨在评估使用冠状动脉内(IC)腺苷进行 IMR 计算。
本研究纳入了 31 例稳定性冠心病患者。使用压力-温度传感器尖端冠状动脉导丝在静息状态和最大充血时进行冠状动脉压力和热稀释测量。首先使用 IC 腺苷,然后使用 IV 腺苷进行重复测量。IC 和 IV 腺苷的渡越时间离散度相当。基于 IC 和 IV 腺苷的 IMR 值具有高度一致性,组内相关系数为 0.90。应用 25 的正常上限,仅在 1 例患者中,IC 腺苷导致 IMR 值较低,存在 IMR 值的错误分类。基于单次盐水推注的简化程序并未改变一致性水平或错误分类率。
我们发现,与 IV 腺苷相比,IC 腺苷诱导的充血期间测量的 IMR 值具有极好的一致性。与 IV 输注相比,使用 IC 腺苷可能更便于进行微血管功能的有创评估,并且潜在地可以节省时间和成本,同时减少患者不适。该试验已在 NCT03369184 注册。